SCHEMBL10036633

SCHEMBL10036633

CSCCNC(=O)CCC(=O)NCCSC

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.62
SMN1; SMN2 Q16637 3/20 0.43
RAB9A P51151 2/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
NPC1 O15118 2/20 0.43
TP53 P04637 1/20 0.43
HPGD P15428 1/20 0.43
NFKB1 P19838 1/20 0.43
MAPK1 P28482 1/20 0.43
NFKB2 Q00653 1/20 0.43
RELA Q04206 1/20 0.43
TSHR P16473 2/20 0.41
CASP2 P42575 1/20 0.40
NAAA Q02083 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
FAAH O00519 3/20 0.36
LPAR1 Q92633 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13225553 0.91 ALDH1A1 (0.58) ALDH1A1SMN1; SMN2RAB9AL3MBTL1NPC1
SCHEMBL1101631 0.89 ALDH1A1 (0.56) ALDH1A1SMN1; SMN2RAB9AL3MBTL1NPC1
SCHEMBL3548845 0.87 ALDH1A1 (0.54) ALDH1A1SMN1; SMN2RAB9AL3MBTL1NPC1
SCHEMBL13469003 0.86 ALDH1A1 (0.48) ALDH1A1SMN1; SMN2RAB9AHPGDKMT2A
SCHEMBL22268862 0.85 ALDH1A1 (0.52) ALDH1A1SMN1; SMN2RAB9AL3MBTL1NPC1
SCHEMBL12107776 0.85 ALDH1A1 (0.52) ALDH1A1HPGDCASP2NAAAFAAH
SCHEMBL19125639 0.83 ALDH1A1 (0.52) ALDH1A1SMN1; SMN2RAB9AL3MBTL1NPC1
SCHEMBL13407579 0.83 ALDH1A1 (0.50) ALDH1A1SMN1; SMN2RAB9AL3MBTL1NPC1
SCHEMBL7649871 0.83 ALDH1A1 (0.60) ALDH1A1SMN1; SMN2RAB9AL3MBTL1NPC1
SCHEMBL226350 0.83

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8092833-B2 Compositions containing inclusion complexes CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2012-01-10 US disclosed
US-20110182864-A1 COMPOSITIONS CONTAINING INCLUSION COMPLEXES CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2011-07-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110182864-A1 COMPOSITIONS CONTAINING INCLUSION COMPLEXES EXOSC5, EXOSC9, INTS6 ALDH1A1 2996/4885SMN1; SMN2 309/4885RAB9A 4206/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.